Biotechnology Press Releases

Published on February 10, 2021 - 12:11 GMT

European Commission Grants Vico Therapeutics Orphan Drug Designation for VO659, an Investigational Therapy for Spinocerebellar ...

LEIDEN, The Netherlands, February 10, 2021 / B3C newswire / -- Vico Therapeutics, a Leiden, the Netherlands, based biotech company focusing on the development of RNA modulating therapies for rare neurological disorders, today announced that the European …

Distribution channels: Technology

Published on February 10, 2021 - 12:11 GMT

Thrombolytic Science Reinforces Its IP Portfolio with Patents in Europe, the Commonwealth of Independent States and Japan

New Patents to Support Global Partnering of Novel Bio-inspired Clot-dissolving Therapy CAMBRIDGE, MA, February 10, 2021 / B3C newswire / -- Thrombolytic Science, LLC (TSI) today announced the granting of three new patents during the last 12 months. The …

Distribution channels: Technology

Published on February 4, 2021 - 19:32 GMT

BD Announces Assay for Identification of COVID-19 Patients at Increased Relative Risks of Intubation with Mechanical Ventilation, ...

In conjunction with clinical findings and the results of other laboratory testing, BD Multitest™ 6-Color TBNK Reagent with BD Trucount™ Tubes may help clinicians determine the risks of Intubation with Mechanical Ventilation and also of mortality in COVID- …

Distribution channels: Technology

Published on February 2, 2021 - 08:30 GMT

Scenic Biotech Appoints Dr. Philippe Dro as Independent Chairman

Philippe Dro brings entrepreneurial expertise and biotech, medtech and pharma industry experience Successful serial entrepreneur with track record of growing companies, notably for Themis and GlycoVaxyn Joins at a key juncture in Scenic Biotech’s strategic …

Distribution channels: Technology

Published on February 2, 2021 - 08:00 GMT

Harbour BioMed and ProBioGen Agree on a GlymaxX® License to Fast-Track Cell Line Development Projects

BERLIN, Germany and SHANGHAI, China, February 02, 2021 / B3C newswire / -- ProBioGen AG and Harbour BioMed today jointly announced their agreement on a cell line development project and application of the ADCC-enhancement technology GlymaxX®. Harbour …

Distribution channels: Technology

Published on February 1, 2021 - 20:17 GMT

Recipharm and Medspray Launch Resyca Joint Venture to Exploit Novel Softmist Technology for Pharmaceutical Applications

ENSCHEDE, the Netherlands, February 01, 2021 / B3C newswire / -- Recipharm AB (publ) (“Recipharm”), a leading contract development and manufacturing organisation (CDMO) and Medspray BV (“Medspray”), a manufacturer of high tech spray nozzles, announce that …

Distribution channels: Technology

Published on January 29, 2021 - 14:09 GMT

Toxys, Leiden University and Leiden University Medical Center Announce Licensing of ToxProfiler Technology for Animal-Free ...

Toxys will immediately commercialize and develop further the in vitro reporter technology for mechanistic toxicity testing to improve the human safety assessment of novel medicines, chemicals and cosmetic ingredients. LEIDEN, The Netherlands, January 28 …

Distribution channels: Technology

Published on January 26, 2021 - 14:12 GMT

86% of Doctors Believe Mental Health Issues, Depression Will be the Biggest non-COVID-19 Issue as a Result of the Pandemic

Two out of Three Do Not Believe or Are Unsure Whether the U.S. and World Will Return to Normal Following Vaccine Rollout NEW YORK, January 26, 2021 / B3C newswire / -- One year after the first COVID-19 case in the U.S., Sermo surveyed physicians around …

Distribution channels: Technology

Published on January 26, 2021 - 09:28 GMT

BioMed X Institute Starts New Research Project in Drug Delivery in Collaboration with Janssen

BioMed X Institute expands its collaboration, facilitated by Johnson & Johnson Innovation, with a third research program in the field of drug delivery New crowdsourcing project to examine the ‘Translocation of Complex Macromolecules Across the …

Distribution channels: Technology

Published on January 21, 2021 - 17:16 GMT

ProBioGen Licenses GlymaxX® Technology to AbbVie

ADCC-Enhancement for Innovative Therapies BERLIN, Germany, January 21, 2021 / B3C newswire / -- ProBioGen AG has signed a commercial license agreement with AbbVie for applying ProBioGen’s proprietary GlymaxX® technology to boost the antibody-dependent cell …

Distribution channels: Technology

Published on January 20, 2021 - 16:19 GMT

Impel NeuroPharma Announces U.S. Food & Drug Administration Acceptance of New Drug Application for INP104 for the Acute Treatment ...

FDA Conditionally Accepts Trade Name, TRUDHESA™, Pending Approval of the NDA, and Sets PDUFA Goal Date of September 6, 2021 Company’s Lead Candidate is Based on Impel’s Proprietary Precision Olfactory Delivery (POD®) Technology, and is the First and Only …

Distribution channels: Technology

Published on January 18, 2021 - 11:02 GMT

Implandata’s EYEMATE System Protects Glaucoma Patients – Even During Lockdown

HANNOVER, Germany, January 18, 2021 / B3C newswire / -- People with glaucoma and eye doctors face a dilemma. On one hand, patients with glaucoma are at high risk of losing their eyesight if their disease progresses undetected and essential therapy …

Distribution channels: Technology

Published on January 15, 2021 - 11:59 GMT

In-Person and Virtual Pharma Partnering Combined

HEIDELBERG, Germany, January 15, 2021 / B3C newswire / -- With completely new algorithms running behind the scenes four new Marketplaces for Pharma Business Opportunities have been confirmed by the Heidelberg, Germany, based RauCon GmbH & Co. KG. Each …

Distribution channels: Technology

Published on January 11, 2021 - 15:02 GMT

Byondis Announces Upcoming Presentation at J.P. Morgan Healthcare Conference

Presentation and webcast to take place at: 07:30 AM EST on January 14 NIJMEGEN, The Netherlands, January 11, 2021 / B3C newswire / -- Byondis, a clinical-stage biopharmaceutical company today announced that its Chief Executive Officer, Marco Timmers, Ph.D …

Distribution channels: Technology

Published on December 21, 2020 - 13:45 GMT

BioMedion AG Announces the Acquisition of the Compliance Division of arivis AG

BERLIN and MUNICH, Germany , December 21, 2020 / B3C newswire / -- BioMedion AG (“BioMedion” or the “Company”) a global Compliance Management Software company providing controlled content and raw data management solutions for the life science industry, …

Distribution channels: Technology

Published on December 17, 2020 - 08:12 GMT

Immune Regulation Appoints New Chairman and Builds Out Senior Management Team with Standout Industry Professionals in the US

LONDON, UK and NEW ORLEANS, US, December 17, 2020 / B3C newswire / -- Immune Regulation Ltd, a US and UK based clinical stage biotechnology company announced today a series of appointments to build out the Board and leadership team that will work alongside …

Distribution channels: Technology

Published on December 16, 2020 - 13:24 GMT

Relaxera and CBL Patras Announce Exclusive Agreement on Manufacturing and Sales of Synthetic Human Relaxin-2

BENSHEIM, Germany and PATRAS, Greece, December 16, 2020 / B3C newswire / -- Relaxera Pharmazeutische Gesellschaft mbH & Co. KG and CBL Patras (Chemical and Biopharmaceutical Laboratories) announce the signing of an exclusive contract for human relaxin- …

Distribution channels: Technology

Published on December 14, 2020 - 13:07 GMT

Pepscope Secures Investment to Radically Improve Development and Application of Kinase Inhibitor Therapies

NIJMEGEN, the Netherlands, December 14, 2020 / B3C newswire / -- Pepscope is a Dutch biotechnology company offering innovative endogenous protein kinase activity profiling technologies. Today, Pepscope announces a 4.3-million-euro funding round, led by …

Distribution channels: Technology

Published on December 11, 2020 - 13:02 GMT

Puma Biotechnology Presents Final Overall Survival Analysis from the Phase III ExteNET Trial at the 2020 SABCS

Results show continued efficacy of neratinib in patients with HER2-positive early stage breast cancer LOS ANGELES, Calif., December 11, 2020 / B3C newswire / -- Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that efficacy …

Distribution channels: Technology

Published on December 9, 2020 - 14:38 GMT

New Clinical Trial Data Demonstrates BD Libertas™ Wearable Injector as a Drug Delivery System

FRANKLIN LAKES, N.J., December 09, 2020 / B3C newswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced publication of the results from a 52-subject human clinical trial with the BD Libertas …

Distribution channels: Technology

Biotechnology Press Releases Distributed by EIN Presswire